ACAD
38.19
+0.22
+0.58%
AEMD
0.19
+0.00
+1.53%
APRI
2.48
+0.28
+12.73%
ARNA
4.27
-0.24
-5.36%
ATEC
1.5
+0.05
+3.45%
CFN
60.19
+0.11
+0.18%
CNAT
6.18
-0.18
-2.83%
CRXM
0.21
+0.00
+1.42%
CYTX
1.13
+0.01
+0.45%
DXCM
59.49
-1.25
-2.06%
GNMK
13
+0.29
+2.28%
HALO
15.27
+0.2
+1.33%
ILMN
194.18
-1.28
-0.65%
INNV
0.17
+0.02
+9.68%
INO
7.17
+0.1
+1.35%
ISCO
0.06
0.00
-1.25%
ISIS
66.73
-1.83
-2.67%
LGND
63.48
+8.41
+15.26%
LPTN
2.94
+0.01
+0.34%
MBVX
0.9
-0.04
-4.26%
MEIP
5.63
-0.26
-4.41%
MNOV
3.54
0.00
0.00%
MRTX
24.14
+0.37
+1.56%
MSTX
0.54
+0.02
+2.88%
NBIX
40.54
+1.49
+3.82%
NUVA
44.8
-0.95
-2.08%
ONCS
0.36
-0.01
-3.17%
ONVO
5.76
-0.16
-2.70%
OREX
5.77
+0.13
+2.30%
OTIC
36.45
-0.63
-1.70%
QDEL
26.42
+0.74
+2.88%
RCPT
127.27
+0.63
+0.50%
RGLS
18.59
+0.07
+0.38%
RMD
64.7
+0.34
+0.53%
SCIE
0.03
0.00
-9.09%
SPHS
0.74
-0.06
-7.24%
SRNE
12.91
-0.01
-0.08%
TROV
6.02
+0.37
+6.55%
VICL
0.99
-0.03
-2.96%
VOLC
17.99
0.00
0.00%
ZGNX
1.69
+0.01
+0.60%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …